|
|
 | | | |
- close
- close
- close
- close
Powershares Global Biotech Portfolio ETF (PBTQ) |
QUOTE AND NEWS
Wall Street Sector Selector
Oct 20
Comment
In midday trading Wednesday, the iPath DJ-UBS Cotton TR Sub-Idx ETN (NYSE:BAL) is outperforming other ETFs, up about 5.5% on the day. Also up on the day are the (...)Read the rest of Wednesday, October 20th ETF Movers: (BAL, FAA, MDD, PLTM, VXX,...
Wall Street Sector Selector
Jun 15
Comment
In trading on Tuesday, the iShares MSCI ACWI ex US Financials Sector Index Fund ETF (AXFN) is outperforming other ETFs, up about 6.4% on the day. Also up on the day are the iShares MSCI Spain Index (EWP) up 5.74%, and the (...)Read the rest of...
Forbes
Mar 25
Comment
In midday trading Thursday, the Broadband HOLDRS ETF (BDH) is outperforming other ETFs, up about 4. 4% on the day.
TheStreet.com
Oct 28
Comment
A group of PowerShares exchange traded funds received initial "buy" ratings as their holdings stand to gain from stronger demand for coal to gold to steel.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
This article describes an exchange traded fund that tracks an index, commodity, currency, or varied basket of securites. View articles referencing this fund. |
TOP CONTRIBUTORS
Global Biotech Portfolio ETF (PBTQ)
Overview
The PowerShares Global Biotech Portfolio (Fund) is based on the NASDAQ OMX Global Biotechnology IndexSM (Index). The Fund will normally invest at least 90% of its total assets in securities that comprise the Index and ADRs and GDRs based on the securities in the Index. The Index is designed to measure the overall performance of globally traded securities of the largest and most liquid companies involved in the biotechnology industry. The Index is rebalanced quarterly using a modified, market-cap-weighted methodology. [1]
Fund Information
- Fund Manager - Invesco Powershares
- Inception Date - 09/18/2008
- Exchange – NASDAQ Exchange
- Index Ticker - PBTQ
- Intra-day NAV Ticker – PBTQ.IV
- Expense Ratio - 0.75%
Top Holdings
| Holdings | % of Portfolio |
| CSL Ltd. | 8.85% |
| Celgene Corp. | 8.31% |
| Gilead Sciences Inc. | 8.01% |
| Genzyme Corp. | 7.79% |
| Amgen Inc. | 7.62% |
| Actelion Ltd. | 4.12% |
| Vertex Pharmaceuticals Inc. | 3.73% |
| Cephalon Inc. | 3.72% |
| Biogen Idec Inc. | 3.71% |
| Alexion Pharmaceuticals Inc. | 3.63% |
Holdings as of 27/10/2009
Other Bio-Technology ETFs
| ETF Name | Fund Manager | Expense Ratio |
| Biotech HOLDRS ETF (BBH) | Merrill Lynch, Pierce, Fenner & Smith HOLDRS | N/A |
| First Trust AMEX Biotechnology Index Fund (FBT) | First Trust Advisors L.P | 0.60% |
| Global Biotech Portfolio ETF (PBTQ) | Invesco PowerShares | 0.75% |
| iShares Nasdaq Biotechnology Index Fund (IBB) | ishares | 0.48% |
| Powershares Dynamic Biotechnology & Genome Portfolio ETF (PBE) | Invesco PowerShares | 0.60% |
| SPDR S&P Biotech ETF (XBI) | State Street Global Markets, LLC | 0.35% |
References
| |||||||
